157 related articles for article (PubMed ID: 9521094)
1. Effects of chronic hyperprolactinemia on tuberoinfundibular dopaminergic neurons.
MohanKumar PS; MohanKumar SM; Arbogast L; Quadri SK; Voogt JL
Proc Soc Exp Biol Med; 1998 Apr; 217(4):461-5. PubMed ID: 9521094
[TBL] [Abstract][Full Text] [Related]
2. The responsiveness of tuberoinfundibular dopaminergic neurons to prolactin feedback is diminished between early lactation and midlactation in the rat.
Arbogast LA; Voogt JL
Endocrinology; 1996 Jan; 137(1):47-54. PubMed ID: 8536641
[TBL] [Abstract][Full Text] [Related]
3. Effects of chronic bromocriptine treatment on tyrosine hydroxylase (TH) mRNA expression, TH activity and median eminence dopamine concentrations in ageing rats.
MohanKumar PS; MohanKumar SM; Quadri SK; Voogt JL
J Neuroendocrinol; 2001 Mar; 13(3):261-9. PubMed ID: 11207940
[TBL] [Abstract][Full Text] [Related]
4. A trophoblast-specific factor(s) suppresses circulating prolactin levels and increases tyrosine hydroxylase activity in tuberoinfundibular dopaminergic neurons.
Arbogast LA; Soares MJ; Tomogane H; Voogt JL
Endocrinology; 1992 Jul; 131(1):105-13. PubMed ID: 1351837
[TBL] [Abstract][Full Text] [Related]
5. Estrogen inhibits tuberoinfundibular dopaminergic neurons but does not cause irreversible damage.
Morel GR; Carón RW; Cónsole GM; Soaje M; Sosa YE; Rodríguez SS; Jahn GA; Goya RG
Brain Res Bull; 2009 Dec; 80(6):347-52. PubMed ID: 19744546
[TBL] [Abstract][Full Text] [Related]
6. Prolactin regulation of tuberoinfundibular dopaminergic neurons: immunoneutralization studies.
Hentschel K; Fleckenstein AE; Toney TW; Lawson DM; Moore KE; Lookingland KJ
Brain Res; 2000 Jan; 852(1):28-36. PubMed ID: 10661492
[TBL] [Abstract][Full Text] [Related]
7. Chronic hyperprolactinemia and changes in dopamine neurons.
Mohankumar PS; Mohankumar SM; Quadri SK; Voogt JL
Brain Res Bull; 1997; 42(6):435-41. PubMed ID: 9128918
[TBL] [Abstract][Full Text] [Related]
8. Chronic estradiol exposure induces oxidative stress in the hypothalamus to decrease hypothalamic dopamine and cause hyperprolactinemia.
MohanKumar SM; Kasturi BS; Shin AC; Balasubramanian P; Gilbreath ET; Subramanian M; Mohankumar PS
Am J Physiol Regul Integr Comp Physiol; 2011 Mar; 300(3):R693-9. PubMed ID: 21178126
[TBL] [Abstract][Full Text] [Related]
9. Pituitary adenylate cyclase-activating polypeptide (PACAP) increases prolactin release and tuberoinfundibular dopaminergic neuronal activity.
Arbogast LA; Voogt JL
Brain Res; 1994 Aug; 655(1-2):17-24. PubMed ID: 7812770
[TBL] [Abstract][Full Text] [Related]
10. Feedback effects of placental lactogens on prolactin levels and Fos-related antigen immunoreactivity of tuberoinfundibular dopaminergic neurons in the arcuate nucleus during pregnancy in the rat.
Lee Y; Voogt JL
Endocrinology; 1999 May; 140(5):2159-66. PubMed ID: 10218967
[TBL] [Abstract][Full Text] [Related]
11. Hyperprolactinemia increases and hypoprolactinemia decreases tyrosine hydroxylase messenger ribonucleic acid levels in the arcuate nuclei, but not the substantia nigra or zona incerta.
Arbogast LA; Voogt JL
Endocrinology; 1991 Feb; 128(2):997-1005. PubMed ID: 1703487
[TBL] [Abstract][Full Text] [Related]
12. Induction of proenkephalin in tuberoinfundibular dopaminergic neurons by hyperprolactinemia: the role of sex steroids.
Merchenthaler I; Lennard DE; Cianchetta P; Merchenthaler A; Bronstein D
Endocrinology; 1995 Jun; 136(6):2442-50. PubMed ID: 7750466
[TBL] [Abstract][Full Text] [Related]
13. Effects of dehydroepiandrosterone (DHEA) on pituitary prolactin and arcuate nucleus neuron tyrosine hydroxylase mRNA levels in the rat.
Garcia de Yebenes E; Hong M; Pelletier G
J Neuroendocrinol; 1995 Aug; 7(8):589-95. PubMed ID: 8704732
[TBL] [Abstract][Full Text] [Related]
14. Effects of opioid antagonism on prolactin secretion and c-Fos/TH expression during lactation in rats.
Zhang B; Hou Y; Voogt JL
Endocrine; 2004 Nov; 25(2):131-6. PubMed ID: 15711026
[TBL] [Abstract][Full Text] [Related]
15. Changes in tuberoinfundibular dopaminergic neuron activity during the rat estrous cycle in relation to the prolactin surge: alteration by a mammary carcinogen.
Pasqualini C; Bojda F; Gaudoux F; Guibert B; Leviel V; Teissier E; Rips R; Kerdelhue B
Neuroendocrinology; 1988 Sep; 48(3):320-7. PubMed ID: 2903462
[TBL] [Abstract][Full Text] [Related]
16. Endogenous opioid peptides contribute to suckling-induced prolactin release by suppressing tyrosine hydroxylase activity and messenger ribonucleic acid levels in tuberoinfundibular dopaminergic neurons.
Arbogast LA; Voogt JL
Endocrinology; 1998 Jun; 139(6):2857-62. PubMed ID: 9607794
[TBL] [Abstract][Full Text] [Related]
17. Mass and in situ activity of tyrosine hydroxylase in the median eminence: effect of hyperprolactinemia.
Gonzalez HA; Porter JC
Endocrinology; 1988 May; 122(5):2272-7. PubMed ID: 2896121
[TBL] [Abstract][Full Text] [Related]
18. Mass and activity of tyrosine hydroxylase in tuberoinfundibular dopaminergic neurons of the aged brain. Control by prolactin and ovarian hormones.
Gonzalez HA; Kedzierski W; Porter JC
Neuroendocrinology; 1988 Dec; 48(6):663-7. PubMed ID: 2907999
[TBL] [Abstract][Full Text] [Related]
19. Progesterone advances the diurnal rhythm of tuberoinfundibular dopaminergic neuronal activity and the prolactin surge in ovariectomized, estrogen-primed rats and in intact proestrous rats.
Yen SH; Pan JT
Endocrinology; 1998 Apr; 139(4):1602-9. PubMed ID: 9528940
[TBL] [Abstract][Full Text] [Related]
20. Characterization of in vitro dopamine synthesis in the median eminence of rats with haloperidol-induced hyperprolactinemia and bromocriptine-induced hypoprolactinemia.
Arita J; Kimura F
Endocrinology; 1986 Oct; 119(4):1666-72. PubMed ID: 3019639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
